StonvexLoading…
StonvexStonvexStonvexCore line items from STVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | €1.19B | €1.10B | €1.09B | €983.68M |
Operating Income | €198.80M | €161.14M | €200.72M | €192.43M |
Net Income | €139.83M | €117.77M | €145.69M | €143.02M |
EPS (Diluted) | €0.51 | €0.43 | €0.55 | €0.54 |
Total Assets | €2.54B | €2.33B | €2.07B | €1.66B |
Total Liabilities | €1.06B | €924.43M | €938.93M | €663.79M |
Cash & Equivalents | €130.60M | €98.27M | €69.60M | €228.74M |
Free Cash Flow OCF − CapEx | €22.32M | €-146.82M | €-328.02M | €-131.72M |
Shares Outstanding | Not available | Not available | Not available | Not available |